|Former: Atención Farmacéutica|
|Journal edited by Rasgo Editorial since 1983|
Manuela Velázquez Prieto
EDITOR IN CHIEF
Jaime E. Poquet Jornet
Tomás Casasín Edo
Virginia Hernández Corredoira
Ramón Jódar Masanés
Juan Carlos Juárez Giménez
Volume 19 - Issue 4, July-August 2017
TREATMENT OF INVASIVE CANDIDIASIS: WHAT GUIDELINES RECOMMEND
GALLEGO MUÑOZ CRISTÓBAL, FERREIRA ALFAYA FRANCISCO JAVIER
Introduction: Candidemia and invasive candidiasis are major causes of morbidity and mortality, and their incidence is increasing because of the growing complexity of patient. Retrospective analyses have shown that early antifungal treatments can improve outcomes. In this update, we review and summarize the main evidence
about treatment of invasive candidiasis according to recommendations of principal guidelines.
Method: An exhaustive search of the published guidelines in referential data sources was performed, up to October 20, 2016.
Results: We included the guidelines of Infectious Diseases Society of America (IDSA) and the European Society for Clinical Microbiology and Infectious Diseases (ESCMID).
Conclusions: Although the recommendations are clear in general, it is difficult to draw any conclusions concerning the choice of antifungal agent and duration of treatment for the less common forms of invasive candidiasis because of the lack of good-quality studies.
GUIDELINES – INVASIVE CANDIDIASIS – TREATMENT